Infinium Global Research Ventricular Assist Device Market | Seite 2

A latest report has been added to the wide database of Ventricular Assist Device Market by Infinium Global
Research. This report studies the Ventricular Assist Device Market by type of indication (left ventricular assist
device, right ventricular assist device, bi-ventricular assist device), application (BTT, BTD, destination, BTR
therapy) market status and outlook of global and major regions, from manufacturers, and end industries. The
objective of the study is to identify market sizes of different segments & countries in recent years and to
forecast the values for the next six years. Ventricular Assist Device Market provides opportunities in micro
markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and
product offerings of the major companies in the Ventricular Assist Device Market. According to the report the
Global Ventricular Assist Device Market is projected to grow at a CAGR of 14.7% in terms of value over the
period of 2017-2023. A VAD or Ventricular Assist Device is an electromechanical pump that is implanted inside
a person’s chest for assisting cardiac circulation, which is used to either to partially or to completely replace
the function of a weakened heart.
A ventricular assist device is dissimilar from an artificial cardiac pacemaker. An artificial cardiac pacemaker
replaces the weak heart permanently, whereas a VAD works with the heart to help it pump more blood with
less work. It does this by continuously taking blood from the ventricle and moving it to the aorta, which then
delivers oxygen-rich blood throughout the body. Some of the ventricular assist devices are used for short
term, typically for patients recovering from myocardial infarction and for patients recovering from heart
surgery; and some are used for long-term, which includes for patients suffering from advanced congestive
heart failure. Moreover, these ventricular assist devices are designed to assist either right ventricle or the left
ventricle or to assist both ventricles. Among these, LVAD implantations are huge in number and accounted for
highest market share due to a high number of patients suffering from left ventricular disease. Surgeons
implant this device as a treatment option for severe heart conditions such as heart failures, and chronic
cardiac function disorders. The ventricular assist devices mechanical pump has both internal and external
components. The actual pump sits on or next to heart’s ventricle with a tube attached that routes the blood to
aorta. A cable called driveline extends from the pump, out through the skin, and connects the pump to a
Infinium Global Research